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During lactation, women can lose up to 10% of bone mineral density (BMD) at 
trabecular-rich sites. Previous studies report resistance exercise to slow BMD losses; 
however, no study has looked at the long-term effects of exercise on BMD during 
lactation. The purpose of this study was to evaluate the effect of a 16-wk exercise 
intervention in lactating women from 4-20 wk postpartum on lumbar spine, total body, 
and hip BMD at 1-y postpartum. 
At 4 wk postpartum, women were randomized to the intervention group [IG, n = 
18, weight bearing aerobic exercise and resistance exercise] or control group [CG, n = 18, 
no exercise] for 16 wk. BMD was measured by dual-energy x-ray absorptiometry at 
lumbar spine, hip, and total body. Repeated-measures ANCOVA was used to test for time 
and group differences for bone density controlling for covariates: prolactin concentration 
and calcium intake at 1-y postpartum.  
IG lost less lumbar spine BMD from 4 to 20 wk postpartum compared to CG (-3.6 
± 2.1% vs. -5.2 ± 3.3%) and gained similarly from 20 wk to 1-y  (IG: 2.7 ± 3.6% vs. CG: 
2.7 ± 3.1%). Change in lumbar spine BMD was significantly different over time and 
between groups from 4 wk to 1-y, when controlling for covariates. No significant 
differences were seen in total body and hip BMD. These results suggest that resistance 
exercise may slow bone loss during lactation, resulting in higher BMD levels at 1-y.
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CHAPTER I 
 
INTRODUCTION 
 
 
Osteoporosis and osteopenia affects approximately 35 million women in the 
United States and continues to rise each year (1). Environmental factors such as excessive 
alcohol intake, poor dietary status, and a sedentary lifestyle increase the risk for the 
development of this chronic disease (1). Additionally, early bone loss from pregnancy 
and lactation has been implicated as a risk factor for low bone mass (1). Specifically 
during lactation, women can lose up to 10% of bone mineral density (BMD) at 
trabecular-rich sites (lumbar spine, hip, femur, and distal radius) (2). Most women’s bone 
mass is recovered with weaning; however, adolescent mothers, women with short child 
spacing, and older women who give birth close to menopausal age may not see complete 
bone recovery, leading to osteoporosis later in life (1). 
Exercise strengthens bones by increasing bone formation and decreasing bone 
resorption (Insert reference). Two studies have examined a 16-week exercise program in 
breastfeeding mothers: Breastfeeding and Exercise for Healthy Infants and Postpartum 
Moms (Be Hip Mom) study and Breastfeeding and Exercise for Healthy Infants and 
Postpartum Moms Too! (Be Hip Mom Too!) (3-4). In addition to the exercise program, 
the Be Hip Mom Too study included a weight loss component through energy restriction. 
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Participants in the intervention group of the Be Hip Mom Too study used MyPyramid 
Menu Planner for Moms (5) to record dietary intake daily.  
At the end of the 16 weeks in the Be Hip Mom study, the exercise group lost 
significantly less lumbar spine BMD compared to those who were leading sedentary 
lifestyles (-4.8 ± 0.6% vs. -7.0 ± 0.3%)(3). In the Be Hip Mom Too! study, lumbar spine 
BMD losses were similar in each group, (IG: -3.4 ± 2.5% vs. CG: -3.7 ± 3.3%).  
The proposed study extends the follow-up time from the two studies to determine 
the effect of exercise during early lactation on lactation-induced bone loss at one-year 
postpartum. The specific aim of this study was to evaluate the effect of a 16-week 
exercise intervention in lactating women from four to 20 weeks postpartum on lumbar 
spine and hip BMD at one-year postpartum. We hypothesized that women who exercised 
would lose less lumbar spine and total hip BMD at one-year postpartum compared to 
those who remained sedentary. We measured dietary intake, hormones, and weight 
change during this time; these were covariates when analyzing the data. This is the first 
study to examine the effects of a supervised, randomized exercise intervention on the 
BMD of lactating women during the first year postpartum.  
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CHAPTER II 
REVIEW OF THE LITERATURE 
Effects of Lactation and Hormonal Response on Bone Mineral Density 
By 6 months postpartum, lactating women lose 3-10% of bone mineral density 
(BMD) at trabecular-rich sites (lumbar spine, hip, femur, and distal radius), equivalent to 
2 years of bone loss in women during menopause (1-3). It is known that hormonal 
changes of prolactin, estrogen, progesterone, luteinizing hormone (LH), follicle 
stimulating hormone (FSH), and parathyroid hormone-related peptide (PTHrP) effect 
BMD during lactation (2). 
Prolactin, the hormone that stimulates breast milk production in response to infant 
suckling, rises approximately 10 to 20 times above normal during pregnancy. In lactation, 
prolactin levels become elevated each time infant suckling takes place. Prolactin is also 
responsible for inhibiting both LH and FSH, leading to decreased levels of estrogen and 
progesterone. In addition, prolactin regulates the synthesis of PTHrP in mammary tissue 
(2). The increase of PTHrP, caused by elevated prolactin levels, combined with the low 
levels of estrogen upregulates maternal bone resorption and the release of calcium into 
the bloodstream to be transferred into breast milk for the infant (4).  
The exact mechanism by which these hormones actually influences bone 
resorption is still unclear. To examine specific hormones on BMD, Krebs et al. (5) 
followed 34 postpartum women (26 fully lactating women and eight non-lactating 
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women) for 7 months with a follow-up at postweaning (6 months after resumption of 
menses; about 15 months postpartum). Fifteen of the lactating women completed the 
postweaning follow-up. Biochemical analysis of hormones, including estradiol and 
prolactin, and BMD measurements was obtained 0.5, 3, 5, and 7 months postpartum. 
Repeated-measures analysis of variance was conducted on BMD by time (linear and 
quadratic), group, and time by group. Stepwise regression with backward elimination was 
used to predict changes of lumbar spine BMD between 0.5 and 3 months. Independent 
variables included maternal characteristics: age, parity, height, weight at each cycle, and 
body mass index (BMI); maternal diet: energy, protein, dietary and total calcium, ratio of 
calcium to protein, phosphorus, and supplemental vitamin D; infant milk intake; estrogen 
and prolactin concentrations. With the initiation of lactation, prolactin concentration 
peaked (140 µg/L) but decreased at 7 months postpartum and 15 months postpartum to 
levels similar to non-lactating women (50 µg/L and 20 µg/L, respectively). Lumbar spine 
BMD declined by 0.049 ± 0.072 g/cm2 during early lactation (0.5 to 3 months) but 
steadily increased to baseline levels at postweaning measurement. Prolactin was not 
significantly related to changes in BMD. At 3 and 5 months postpartum, lactating women 
had significantly lower estradiol concentration (100 pmol/L); however, once lactation had 
ceased, estradiol concentration was comparable to that of the non-lactating women 
measured at seven months postpartum (250 pmol/L). Additionally, estradiol 
concentration was positively associated with change in lumbar spine BMD (p < 0.001). 
Although PTHrP was not measured, intact parathyroid hormone was found to be lower in 
lactating participants. Research suggests an inverse correlation between serum 
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parathyroid hormone and PTHrP (6, 7). It is possible that the hormones estradiol, 
prolactin, PTHrP all work together to affect BMD.  
The recent research on PTHrP is limited; however, when evaluating the 
relationship of elevated PTHrP and decreased concentrations of estrogen on BMD in 
lactating mice, bone resorption and BMD losses are enhanced (8, 9). Sowers et al. (10) 
examined the role of PTHrP on BMD by recruiting 115 postpartum women in an 18-
month prospective cohort. When controlling for prolactin concentration, breastfeeding 
status, return of menstruation, estradiol concentration, PTH levels, 1,25-
dihydroxyvitmain D levels, dietary calcium, self-reported physical activity, and BMI, 
elevated PTHrP levels were negatively and significantly associated with BMD change at 
both the lumbar spine and femoral neck over time (p < 0.01). Elevated PTHrP was also 
associated with elevated prolactin concentration, breastfeeding status, and reduced 
estradiol concentration (p < 0.001), further reinforcing that these hormones are dependent 
on each other during lactation. 
BMD losses usually return to baseline (about 2 to 4 weeks postpartum) 
measurements once lactation ceases and menses resumes. This is primarily due to the 
hormones of prolactin and estrogen returning to prepregnant levels (prolactin decreases 
and estrogen increases). A recent retrospective study conducted by Wiklund et al. (11) 
found that a longer lactation duration, defined as the total months breastfeeding 
(exclusively and partial) reported by the mother, was associated with improved bone size 
and strength 16 to 20 years after lactation ended. Women who breastfed for longer than 
33 months were more likely to have larger and stronger bones later in life. One plausible 
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mechanism the authors suggested is that low estrogen levels during lactation are 
associated with stimulated periosteal bone formation, which is formed around the outside 
surface of the bone and contributes to larger and stronger bones. Unfortunately, a 
limitation to this study was that they did not measure estrogen status to provide evidence. 
Most research has shown that a chronically low level of estrogen contributes to an 
increase in bone turnover. While this is the first study to suggest lactation duration being 
protective of BMD later in life, contrary to others who have only seen the association 
with parity (12, 13), these findings should be taken with caution.   
Paton et al. (12) conducted a study of twins and found that pregnancy and 
lactation did not have any harmful effects on bone mineral content. The study was 
divided into three smaller studies. The first studied examined 83 twin pairs of nulliparous 
and multiparous women. There were no BMD differences observed between parous 
groups. The second study consisted of 498 twin pairs who were divided into three groups: 
1) nulliparous, 2) one to two pregnancies, and 3) three or more pregnancies. Group 3 had 
significantly higher total body bone mineral content compared to group 1 (p = 0.03). The 
third study was a cross-sectional analysis of 1354 individual women consisting of twin 
pairs, sister pairs, and their female relatives. The participants were grouped as described 
above. Adjusted lumbar spine BMD and total bone mineral content was higher in groups 
2 and 3 compared to group 1 (p = 0.001, p < 0.001, respectively). Additionally, adjusted 
total hip BMD was greater in group 3 compared to group 1 (p = 0.02). Z scores of lumbar 
spine BMD were also higher in groups 2 and 3 than in group 1. Of the 82% who 
breastfed for more than one month, adjusted bone mineral content and total hip BMD was 
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significantly increased in these participants; however, lumbar spine BMD was not 
affected.  
Calcium and Vitamin D Intake and Supplementation during Lactation on 
 
Bone Mineral Density 
 
Bone is the primary storage site for calcium, storing about 99% of the body’s 
calcium. During lactation, skeletal demineralization is mediated by PTHrP (4). As PTHrP 
begins to rise and combines with low concentrations of estradiol in the bloodstream, bone 
resorption is upregulated (4). This results in an increase of calcium and phosphate in the 
bloodstream, where it travels to the breast (4). Approximately 250 mg of calcium is 
transferred from mother to breast milk daily (3). To meet the calcium demand, both bone 
mobilization and renal calcium conservation occurs (4).  
Studies determining the effect of calcium intake on BMD have been inconclusive. 
Krebs et al. (5) reported at postweaning  that both dietary and total calcium intake was 
positively associated with lumbar spine BMD six months after return of menses in well-
nourished lactating women (p = 0.03). In another study, 10 adolescent (aged 15 to 18) 
lactating mothers with habitually low dietary calcium intake (444 ± 288 mg Ca/d) were 
evaluated by Bezerra et al. (15). BMD measurements were conducted at 2 time points: 
lactation (6-24 weeks postpartum) and postweaning (12-30 months postpartum) with four 
24-hour dietary recall questionnaires used to evaluate calcium intake. At postweaning, 
there was a marginally significant relationship between calcium intake and BMD at the 
lumbar spine (p = 0.09). The small sample size may not have had adequate power to 
determine a significant difference. Similar to adult lactating women, adolescents had 
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decreases in BMD during lactation and increases once lactation had ended. Although 
postweaning bone recovery occurs, the rate may not be sufficient to attain peak bone 
mass as the adolescent reaches maturity. This may be due to low calcium intake, which 
can render them prone to the development of osteoporosis later in life.  
Supplementation of calcium has also been studied in its relationship with BMD 
during lactation. Unfortunately, the literature shows that supplementation has little effect 
on BMD (15, 16, 17).  Kalkwarf et al. (16) reported that even though calcium 
supplementation (1 g calcium/d) did not prevent bone loss during lactation in women 
with moderate to low calcium diets (< 800 mg per day), it did slightly enhance bone 
formation in lumbar spine after weaning (p < 0.05). When evaluating the effectiveness of 
calcium supplementation (1 g calcium/d) in lactating Gambian women (n = 60) with 
habitually low calcium intake (< 300 mg/d), Prentice et al. (17) concluded that calcium 
had no effect on bone mineral content; BMD was not measured. One possible mechanism 
proposed was that bone and renal adjustments occur independently from calcium status in 
order to supply calcium to breast milk. The supplementation group had significantly 
higher urinary calcium output compared to the control group three and 12 months after 
beginning supplementation (p ≤ 0.005). Supplemental calcium resulted in a reduction in 
net fractional calcium absorption and/or an increase in calcium excretion.  
In its active form, vitamin D interacts with vitamin-D receptor complexes (VDR-
RXR) causing preosteoclasts to mature. Mature osteoclasts help maintain plasma calcium 
levels by increasing bone resorption if calcium levels are low (18). Fat-soluble vitamin D 
is essential for promoting intestinal calcium absorption. Plasma calcium levels can be 
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maintained by increasing absorption in the gastrointestinal tract. In absence of vitamin D, 
only 10-15% of dietary calcium would be absorbed in the human body (18). 
Polymorphisms of the VDR-genotype have been known to alter calcium 
absorption. A recent study, conducted by Yu et al. (19) evaluated calcium 
supplementation in lactating Chinese women with habitually low calcium intakes (< 600 
mg) with different VDR-genotypes and its effect on BMD. To determine specific VDR-
genotypes, a 265-base pair fragment of genomic DNA was extracted, amplified by 
polymerase chain reaction, and then was digested with Fok1 restriction enzymes. The 
absence of the Fok1 recognition site in the DNA binding domain demonstrates that 
cleavage of the fragment will not occur and the allele is defined as “F”. The presence of 
the Fok1 recognition site is defined as “f”.  
At approximately five weeks postpartum, 120 women were grouped with respect 
to their VDR-genotype (FF, Ff, ff; n = 40 in each group). Women within each group were 
then randomly assigned to subgroups where they either received a supplement (600 mg of 
calcium, n = 20 in each group) or placebo (n = 20 in each group) for one year. 
Measurements were conducted at baseline, defined as the resumption of menses or 
termination of lactation (average of 100 ± 46 days postpartum) and one year thereafter. 
BMD was measured at lumbar spine and left hip at both time points. At baseline, there 
were no significant differences in BMD between the calcium supplemented and placebo 
subgroups in any of the three VDR-genotype groups. At one-year postpartum, BMD 
levels of lumbar spine and left hip significantly increased in the calcium supplemented 
and placebo subgroups of all three VDR-genotypes groups (FF: p < 0.05, Ff: p < 0.01, ff: 
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p < 0.001). Women supplemented with calcium in the VDR-genotype “FF” group had a 
significant increase in percent change of BMD compared to women within the same 
VDR-genotype given the placebo (p < 0.05). Also, there was a significant difference in 
percent change of lumbar spine BMD between the VDR-genotype “FF” and VDR-
genotype “ff” in women who received calcium supplementation (p < 0.05). 
Supplemented women with “ff” VDR-genotype had a lower percent change BMD 
compared to “Ff” and “FF”. The results suggest that women with the VDR-genotype 
“FF” may have a greater absorption of calcium compared to those with other VDR-
genotypes, and when supplementation with calcium occurs, absorption will be further 
amplified. In addition, serum 25(OH)vitaminD3 was not significantly different between 
baseline and one-year follow-up or between groups and ranged approximately 21-30 
ng/mL. This was the first study to examine the effects of Fok1 VDR-genotype in 
postpartum women and suggests that differences within the VDR-genotypes may affect 
BMD status in women.  
Laskey et al. (20) also examined the vitamin D-receptor genotype in breastfeeding 
women; however, the study was conducted in Caucasian lactating women (n = 37) who 
had moderate to high calcium intakes (1392 ± 528 mg/d), assessed by food frequency 
questionnaires and a seven-day food diary. DNA was extracted, amplified by polymerase 
chain reaction, and then digested by using Bsm1 endonuclease. Genotypic polymorphism 
was defined as BB (absence of restriction site on both alleles), bb (presence of restriction 
site on both alleles), or Bb (heterozygous). The VDR-genotype frequency of lactating 
women was: BB, 19%; Bb, 43%; and bb, 38%. Measurements of bone mineral content 
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and bone area were conducted around two weeks postpartum (baseline) and at three 
months postpartum. Although there were significant changes in bone mineral 
composition at the lumbar spine, femoral neck, total hip, and whole body from 0.5 to 
three months postpartum, results found that VDR-genotype and calcium intake were not 
related to these changes before or after adjusting for change in bone area. Limitations to 
this study were 1) a lack of standardizing calcium intake with a supplement to ensure 
adequate intake, 2) small sample size for each VDR-genotype, 3) women were not 
equally distributed in each VDR-genotype, and 4) vitamin D status was not reported. This 
study suggests that the skeletal response during lactation varies from each individual 
through other mechanisms that need to be further explored.   
Currently, the serum vitamin D guidelines are controversial. Historically, vitamin 
D deficiency has been defined as < 20 ng/mL, insufficiency as 20 to 30 ng/mL, and 
sufficiency as greater than or equal to 30 ng/mL (21). Laboratory references from Mayo 
Clinic state that a concentration of 18 to 80 ng/mL of serum vitamin D is considered 
normal (22). It has also been suggested that for adequate calcium absorption, vitamin D 
concentrations should be above 32 ng/mL (23, 24, 25). Guidelines from the Institute of 
Medicine advise that more than or equal to 20 ng/mL is considered sufficient; a 
recommendation that had been under scrutiny since its suggestion (26). However, a 
recent study conducted by Kramer et al. (27) exploring serum vitamin D levels in 15,099 
adults who participated in the Third National Health and Nutrition Examination Survey, 
found that mortality rate was similar across the serum vitamin D range of 20 to 40  
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ng/mL. Additionally, sun exposure, skin pigmentation, and body fat influences serum 
vitamin D (27).  
Serum vitamin D concentration during pregnancy and lactation has not been 
defined. A recent study, conducted by O’Brien et al. (28) examined serum vitamin D 
levels during pregnancy and the postpartum period in two cohorts. The Baltimore, 
Maryland cohort recruited 23 adolescent women (n = 20, African American; n = 3, 
Caucasian) who intended to breastfeed in the postpartum period. From the San Francisco, 
California cohort, 13 adult women (n = 11, Caucasian; n = 3, Hispanic) were recruited. 
Serum vitamin D levels did not differ between pregnancy and the postpartum period or 
by cohort (San Francisco: 19.3 ± 3.7 ng/mL; Baltimore: 22.4 ± 9.0 ng/mL). Another 
study by Basile et al. (29) found serum vitamin D status in lactating women (n = 16, 
Caucasian; n = 9, African American) from South Carolina to be approximately 22.4 ± 8.8 
and 28.5 ± 8.6 mg/dL, at baseline depending on the study group. Additionally, Hollis et 
al. (30) reported a serum vitamin D of 32.9 ng/mL and 27.6 ng/mL at baseline, depending 
on the study group, in lactating participants from South Carolina.     
As stated previously, vitamin D status is important for calcium absorption, and 
with that bone health. However, the relationship between vitamin D deficiency and BMD 
remains inconclusive (31, 32). Andiran et al. (31) examined the effects of vitamin D and 
BMD in 54 lactating mothers in Turkey. People residing in Turkey most often have 
sufficient vitamin D status from the ultraviolet light; unfortunately, women who dress in 
the traditional garments may not receive adequate vitamin D from the sun. Low vitamin 
D status was assessed by evaluating serum 25-hydroxyvitamin D levels; vitamin D 
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insufficiency was defined if levels fell below 40 nmol/L and deficiency was defined if 
levels fell below 25 nmol/L. BMD of L1-L4 vertebra and femur neck region was 
evaluated in 25 mothers who were determined to be vitamin D deficient. Measurements 
taken showed that 10 of these women were osteopenic. Of these women, all were from 
the lower socioeconomic class and eight women wore traditional attire. The study did not 
find any significant relationship between BMD levels and vitamin D levels in deficient 
mothers (p = 0.21, L1-L4 and p = 0.35, femur neck). However, since BMD 
measurements were only conducted in women with low levels of vitamin D, the lack of 
normal distribution could be a plausible reason why significance was not seen. The lack 
of recorded calcium intake is also a limitation in this study.  
Additionally, Ghannam et al. (32), who studied a lactating population in Saudi 
Arabia with similar cultural traditions of wearing covered garments, found that 52% of 
their participants had hypovitaminosis D (24.5 ± 17.2 nmol/L) but the status was not 
correlated with BMD levels. Vitamin D status did correlate positively with serum 
calcium levels. BMD in women with severe hypovitaminosis D was measured by DXA 
and these women had lower z-scores at the spine, femoral neck, Ward’s triangle, and 
trochanter, but BMD did not correlate significantly with vitamin D status. The study 
reports that the lack of effect on BMD was unexpected. One possible explanation is that 
the vitamin D levels in the study are below the threshold needed to maintain normal bone 
mineral density levels.  
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Effects of Exercise on Bone Mineral Density 
There are very few reports on the effects of exercise during lactation on BMD. 
The first study, conducted by Drinkwater and Chestnut (33), observed changes in bone 
mineral density in six postpartum female athletes enrolled in a two year longitudinal 
study. From one month postpartum to six months postpartum, there was a significant 
decrease in femoral neck BMD by 3.1% and lumbar spine BMD increased 3.4%. 
Limitations within the study, including small sample size, lack of a non-exercise control 
group, and absence of defined exercise procedures yielded inconclusive results for 
determining the effect of exercise on bone mineral density. This study suggests that 
exercise may be beneficial in preventing losses in lumbar spine BMD and set the 
foundation for future studies.  
Little and Clapp (34) compared 11 fully breastfeeding women who engaged in 
regular, self-selected recreational exercise for the first three months postpartum with nine 
(control) non-exercising postpartum women. The exercise group was defined by women 
reporting exercising more than three days per week longer than 20 minutes per session at 
more than 50% maximal oxygen consumption. Weight bearing exercise combined with 
aerobic activity was the primary exercise mode for the exercise group. Total body, 
lumbar spine, and femur neck BMD was measured at baseline and three months 
postpartum. At three months postpartum, femoral neck and lumbar spine BMD losses 
were not statistically significant between the exercise group and control group (lumbar 
spine: -4.1% and -5.4%, respectively; femoral neck: -2.8% and -2.7%, respectively). The 
lack of difference may have been due to highly variable exercises (mode, intensity, 
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frequency, and duration) and the length of study (10 weeks). Lack of random assignment 
to exercise or control group was another limitation to the study. The duration of the study 
may not have been long enough and the intensity and type of exercise may not have been 
appropriate to see the adequate effects of bone remodeling with exercise in this 
population.  
The third study focused on weight bearing aerobic exercise combined with 
resistance exercise for 16 weeks in 20 fully lactating postpartum women (35). At four 
weeks postpartum, sedentary women were randomly assigned to an exercise or control 
group. Aerobic exercise consisted of 45 minutes of walking at 65-85% of predicted 
maximum heart rate three days per week. Resistance exercises were completed as a split 
routine three days per week; this focused on strength to the axial skeleton. Lumbar spine 
BMD loss was significantly less in the exercise group compared to the control (-4.8% vs. 
-7%, respectively). Hip and total body BMD were not significantly different between 
groups (total hip: -2.8% exercise vs. -2.2% control; total body: -0.6% exercise vs. -0.8% 
control). This study was the first to see significant effects of exercise on slowing the loss 
of BMD, particularly in the lumbar spine, in lactating women.  
A recent study conducted by Colleran et al. (36) examined the effects of energy 
restriction and resistance exercise on BMD in overweight and obese postpartum lactating 
women. At four weeks postpartum, women (n = 27) were randomly assigned to an 
intervention (diet and exercise; n = 14) or control group (n = 13) for 16 weeks. Energy 
restriction of 500 calories per day was used to promote a 0.5 kg to 1.0 kg weight loss per 
week. Strength exercises (3 days/week) were designed to strengthen the core and 
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included variations of squats, bench press, bent-over row, deadlift, and military press. 
Additionally, this group was advised to walk 10,000 steps or 3,000 aerobic steps per day 
for five days a week. Research assistants traveled to the participants’ homes to ensure 
compliance with the strength training and recorded steps walked. At endpoint, total BMD 
did not change over time in each group. However, lumbar spine and total hip BMD 
significantly decreased over time (p < 0.01); but differences between groups were not 
significant [lumbar spine BMD; exercise: -3.4 % vs. control: -3.7%; Hip BMD; exercise 
and control: -3.1%]. One possible reason as to why significance between groups was not 
observed is that the study population was either overweight or obese compared to normal 
weight participants where significance was seen in the previous study.      
In nonpregnant, nonlactating women with normal estrogen levels, resistance 
training has been shown to increase BMD in both lumbar spine and femoral neck as a 
result of mechanical strain or stress on the bone (37, 38). Krustrup et al. (38) examined 
the effects of a 16 month training program, consisting of either recreational football (FG), 
running (RG), or control group (CG) on bone mineral density in 28 untrained 
premenopausal women (19-47 years old). Training was supervised for one hour twice a 
week for 16 months and DXA measurements were taken at baseline, four and six months. 
Whole body BMD was greater (p <0.05) in FG after 16 months than after baseline and 
four month; BMD changes within FG were greater than RG (p < 0.05).  
In the study conducted by Chilibeck et al. (39), premenopausal women who 
participated in resistance training using only universal weight machines twice a week did 
not demonstrate improvement in total body, femoral neck, or lumbar spine BMD. Liang 
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et al. (40) also observed no improvements in these sites with strength training. However, 
free-weight (dumbbell) resistance training and jumping (impact) have shown marked 
improvements in BMD (41, 42).  
Bassey et al. (43) found that a vertical jumping exercise regime, comprising of 50 
vertical jumps for 20 weeks, significantly improved femoral neck and lumbar spine BMD 
in premenopausal women compared to the control group. Bassey et al. (43) also 
examined the effects of jumping on postmenopausal women. The postmenopausal 
women, not using hormone replacement therapy (HRT), followed a regime of 50 vertical 
jumps everyday for 12 months. Contrary to the results found in the premenopausal 
women, the vertical jumps had no effect on femoral neck or lumbar spine BMD. This 
suggests that alternative methods of training should be applied to increase BMD in 
postmenopausal women.  
Another study reported that aerobic exercise did not affect femoral neck and 
lumbar spine BMD in postmenopausal women (44). However, when combining aerobic 
exercise (treadmill, 50 minutes per session, 3 d/wk) with stepping 96 beats for 10 minutes 
in postmenopausal women, significant improvements in femoral neck and lumbar spine 
BMD were reported (45). In addition, other studies have combined resistance training and 
aerobic exercise and indicate positive effects on BMD in postmenopausal women (46). 
Effects of Weight Loss on Bone Mineral Density 
 Approximately 68% of the American adult population is either overweight or 
obese (47). This excess weight is associated with many health risks; however, this 
population is believed to have a reduced risk for osteoporosis due to greater BMD. This is 
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primarily due to extra loading on the weight bearing skeleton and possibly higher 
circulating concentrations of estrogen (48, 49). Due to the other health risks associated 
with the overweight and obese population, weight reduction is encouraged. Weight loss 
can be achieved by creating an energy deficit by restricting calorie intake, increasing 
energy expenditure, or combining the two. Unfortunately, weight loss has been reported 
to be associated with losses in BMD (50, 51). One possible mechanism suggests that a 
decrease in fat mass causes lower levels of circulating androgen precursors to occur, thus 
decreasing the amount of estrogen and promoting bone loss (49, 52, 53). This is 
particularly a concern for postpartum lactating women with estrogen levels already lower 
and lactation-induced bone loss is occurring. 
The study by Colleran et al. (36), discussed in the previous section, examined the 
effects of weight loss by energy restriction and resistance exercise on BMD in 
overweight and obese postpartum lactating women. Women in the intervention group lost 
significantly more weight compared to the control group at the end of the 16-week 
intervention (-5.8 kg vs. -1.6 kg, respectively; p = 0.03). Total BMD did not change over 
time; however, lumbar spine and total hip BMD significantly decreased over time (p < 
0.01). Group differences were not observed, suggesting that weight loss did not intensify 
lactation-induced bone loss. 
 During the menopausal transition, women experience menopause-induced bone 
loss, losing up to 1.35% of BMD in the spine annually (50). Weight gain of one pound 
per year usually accompanies menopause. Because of this, weight loss is often 
encouraged; however, it may further attenuate bone losses during this critical period. 
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Furthermore, it is important to understand which of the two areas of weight loss (energy 
restriction and increased energy expenditure) promote or prevent bone losses or 
alternative strategies like combining weight loss with exercise to prevent BMD loss.  
 Silverman et al. (54) randomly assigned 86 overweight and obese postmenopausal 
women to a weight loss or combined program of weight loss and walking for six months. 
All participants met weekly with a registered dietitian and were instructed to restrict 
calories by 250-350 kcal/day. Nutritional education was also given to promote a healthy 
lifestyle. In addition to the weight loss instruction, women in the combined group also 
participated in a walking regime three days per week, 45-60 minutes per session. Target 
heart rate of 50-75% maximal was encouraged. At the conclusion of the six month 
intervention, both groups had significant changes in weight (weight loss: -7.6%. 
combined: -7.7%; p < 0.001), BMI (-7.6% in both groups), and fat mass (weight loss: -
15.4%; p < 0.05. combined: -12.5%; p < 0.001). Significant increases in femoral neck 
BMD were observed only in the combined walking and weight loss group at six months 
(+2.01% vs. no change in the control group; p = 0.001). Changes in lumbar spine femoral 
neck BMC and lumbar spine BMC were not seen. The combined group also saw 
improvement by 11% in osteoporosis after the six month intervention compared to only 
6% in the weight loss group (55). Unfortunately, 9% of women in the weight loss group 
saw a worsening in the classification of osteoporosis compared to the 2% in the combined 
group. The study indicates that aerobic exercise in addition to weight loss can also protect 
against menopause-induced bone loss. Wolff et al. (56) conducted a meta-analysis of 
published control trials in pre- and postmenopausal women and found that in almost all 
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studies, weight loss by calorie restriction resulted in higher losses of BMD compared to 
those who achieved weight loss through exercise alone.   
 Contrary to these results, Macdonald et al. (57) found in normal to overweight 
postmenopausal women a correlation between weight loss and femoral neck BMD (r = 
0.102, p = 0.002) but not in lumbar spine (r = 0.026, p = 0.436). For postmenopausal 
women not using hormone replacement therapy, the effects of weight loss on femoral 
neck BMD follow-up weight loss on lumbar spine were stronger than current HRT users; 
however, these results were not significant. When looking at physical activity level, 
women who lost weight and reported greater physical activity showed less decreases in 
lumbar spine BMD compared to those who were inactive. A limitation is that physical 
activity was estimated by a questionnaire, with no clear definition of what type of 
exercise was used.     
 Additional studies have been conducted on premenopausal overweight and obese 
women to further evaluate weight loss and BMD. Uusi-Rasi et al. (58) conducted a three 
month weight loss program in obese (BMI > 30) premenopausal women predominately 
through diet, with a nine month maintenance period.  All participants received the same 
intervention with the weight loss program consisting of three parts: week one, low energy 
diet using the meal-exchange system; weeks two through 10, very low energy diet; and 
weeks 11-12, low energy diet and education on weight maintenance. Women kept a 
physical activity diary and recorded the type, intensity, and duration of the exercise 
completed. Weight reduction resulted in an increase bone turnover, but did not 
compromise bone strength, bone mineral content, or BMD. The study had several 
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limitations including lack of an untreated control group to compare bone strength. Also, 
the weight loss intervention occurred for only three months and exercise logs were used 
for the total duration of the study. It may be plausible that exercise protected the bone 
loss during the time of weight loss and weight maintenance.  
Summary of Literature Review 
 Lactation-induced bone loss is usually reversed with weaning and resumption of 
menses. However, BMD may not return to pre-pregnancy levels in all women. There is a 
concern that these women are at an increased risk of developing osteoporosis later in life. 
Several hormones regulate bone resorption during lactation, including prolactin, estrogen, 
and parathyroid-related peptide (PTHrP). Further research is needed to investigate the 
mechanism of each hormone on BMD during lactation. 
Calcium and vitamin D status also play a major role in bone mineral density. 
During lactation, calcium is transferred out of the bone and into the breast milk for the 
infant. Insufficient calcium levels may promote further bone resorption. However, some 
studies have suggested that those who are low in calcium and supplement with calcium 
do not see prevention of bone loss. Vitamin D is also important for calcium absorption; if 
levels are deficient, only 10-15% of calcium will be absorbed, leading to low serum 
calcium levels. Unfortunately, defined vitamin D status ranges remain controversial. 
Weight bearing aerobic and resistance exercise may protect bone density during lactation 
and may enhance bone maintenance when weight loss is occurring.  
The study conducted by Colleran et al. (36) was the first to look specifically at the 
effects of a 16-week intervention of a supervised, randomized exercise combined with 
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energy restriction on lactation-induced bone loss. Unfortunately, the study only reported 
changes in BMD during the 16-week intervention and did not address BMD at one-year 
postpartum. This measure is important because at one-year postpartum, breast milk is no 
longer the primary source of energy for the infant and in most cases lactation has ceased 
altogether. With the cessation of lactation and the return of menses, BMD usually returns 
to baseline levels. Furthermore, the initiation of exercise during the 16-week intervention 
may enhance bone growth and may still be evident at one-year postpartum. 
Therefore, the purpose of our study was to determine if early exercise (4 to 20 
weeks postpartum) had any effect on lactation-induced bone loss at one-year postpartum, 
using the participants enrolled in our two previous studies – Be Hip Mom and Be Hip 
Mom Too! study. This is the first study to evaluate the long-term effects of supervised, 
randomized exercise during early lactation on BMD at one-year postpartum.         
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CHAPTER III 
 
THE EFFECTS OF DIET AND EXERCISE ON BONE MINERAL DENSITY DURING 
THE FIRST YEAR POSTPARTUM 
 
 
Publication in The American Journal of Clinical Nutrition 
 
 
Introduction 
 
Lactation is a critical period of rapid bone turnover. During lactation, infant 
suckling stimulates prolactin; the hormone responsible for breast milk production, and it 
initiates the release of parathyroid hormone related peptide from the mammary tissue into 
the bloodstream (1). The presence of parathyroid hormone related peptide along with low 
estradiol concentration in the bloodstream upregulates maternal bone resorption (1). 
Calcium from bone is then released into the bloodstream, which will be transferred into 
infant breast milk (1). This increase in bone remodeling results in losses up to 10% of 
maternal bone mineral density (BMD) at the trabecular-rich sites (lumbar spine, hip, 
femur, and distal radius) (2). Once resumption of menses and weaning occurs, most 
women return to their baseline BMD levels; however, adolescent mothers, women with 
short intervals between pregnancies, and older women who give birth close to 
menopausal age may not see complete bone recovery, increasing the risk osteoporosis 
later in life (3).
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Previous studies in non-pregnant, non-lactating women have shown that weight-
bearing exercise promotes BMD by strengthening the bones and preventing bone 
resorption in the lumbar spine and femoral neck (4-7). Additionally, studies examining 
exercise in lactating women have shown decreased losses in lumbar spine BMD. We 
have reported 2 studies examining a 16-wk exercise program in breastfeeding mothers: 
Breastfeeding and Exercise for Healthy Infants and Postpartum Moms (Be Hip Mom) 
study and Breastfeeding and Exercise for Healthy Infants and Postpartum Moms Too! 
(Be Hip Mom Too!) (8,9). In addition to the exercise program, the Be Hip Mom Too! 
study included a weight loss component through energy restriction. At the end of the 16 
wk in the Be Hip Mom study, the exercise group lost significantly less lumbar spine 
BMD compared to those who were leading sedentary lifestyles (-4.8 ± 0.6% vs. -7.0 ± 
0.3%). In the Be Hip Mom Too! study, lumbar spine BMD losses were similar in each 
group (-3.4 ± 2.5% vs. -3.7 ± 3.3%). 
 The purpose of this study was to determine the effect of exercise during early 
lactation on BMD at 1-y postpartum. We hypothesized that women who exercised during 
early lactation would lose less lumbar spine and total hip BMD at 1-y postpartum 
compared to those who remained sedentary. Dietary intake and hormonal status were also 
assessed at 1-y postpartum. 
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Subjects and Methods 
Study participants 
Participants for this study were women enrolled in our 2 previous studies - Be Hip 
Mom and Be Hip Mom Too! (8,9). The Be Hip Mom study examined the effects of 
physical activity (resistance and aerobic exercise) on BMD in postpartum normal and 
overweight breastfeeding women for 16 wk. The Be Hip Mom Too! study examined the 
effects of a 16-wk resistance and aerobic exercise combined with energy restriction on 
BMD in overweight and obese postpartum breastfeeding women. Measurements for both 
studies were conducted at baseline (3 ± 2 wk postpartum) and endpoint (21 ± 2 wk 
postpartum). For this study, participants returned to the lab at 1-y postpartum (52 ± 2 
wk). Measurements were: height; weight; blood draws for hormones; cardiovascular 
fitness and strength testing; 24-hour dietary recalls; and bone area, mineral concentration 
and density. 
Participants were recruited through prenatal and parenting classes offered at the 
local hospital and at local obstetricians’ offices for both studies. Women were eligible if 
they were exclusively breastfeeding, healthy, non-smoking, sedentary for at least three 
months, and had a self-reported body mass index (BMI) between 20 to 30 kg/m2 (Be Hip 
Mom) or between 25 to 30 kg/m2 (Be Hip Mom Too!). Women were excluded if they 
participated in physical activity more than 3 d/wk in the past 3 mo, delivered by cesarean 
section, or had a pre-existing condition that disrupted hormonal levels or made them 
unable to participate in an exercise intervention.  
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A total of 47 women were randomly assigned to IG or CG and completed the 16-
wk intervention (Figure 1). Thirty-four of the women enrolled were White, non-
Hispanic, 3 Black, non-Hispanic (CG = 2, IG = 1), 1 Asian (IG), and 1 Hispanic (IG). All 
women enrolled had a college education. In the Be Hip Mom study, 2 women in IG 
became pregnant and 3 women (IG = 1, CG = 2) were unable to schedule 1-y follow-up 
appointments. Additionally, in the Be Hip Mom Too! study, 5 women were unable to 
schedule a 1-y follow-up visit (IG = 3, CG = 2) and 1 woman in CG became pregnant. 
The final sample size for the combined studies at 1-y follow-up was 36 (18 per group). 
Random assignments to groups were determined after baseline measurements were 
completed. Randomization was stratified by parity to control for prolactin levels, as 
prolactin levels are higher in primiparous compared to multiparous women (10). 
The study was approved by the University of North Carolina at Greensboro’s 
Institutional Review Board. Written informed consent was obtained from all study 
participants.  
Study Design 
Intervention Group 
 After baseline measurements were conducted, participants were randomly 
assigned to IG or CG. Participants in both groups were given a year supply of a 
multivitamin supplement containing 10 mcg of vitamin D. Beginning at 4 wk postpartum; 
women in IG completed a 16-wk home-based exercise program that focused on resistance 
training and aerobic exercise 3 d/wk. The 2 studies had similar intervention protocols 
designed to increase core strength of the body, the area from the gluteal muscles and hip 
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up to the scapula, with the intent of increasing bone formation at lumbar spine and hip. 
Research assistants traveled to the home to ensure exercise compliance. The resistance 
exercises included variations of squats, bench press, standing military press, dead lift, and 
bent-over rows, used in one-repetition maximum (1-RM) testing. All exercises were 
completed at home and participants were given handheld weights and stability balls. 
After the 16-wk intervention, the women in IG were encouraged to continue exercising.  
Both studies included an aerobic component in their intervention. In the Be Hip 
Mom Study, women were instructed to “briskly walk” at an intensity of 65-80% of each 
participant’s predicted maximum heart rate at time of baseline measurements. Heart 
monitors were used to confirm subjects were exercising at the prescribed intensity. 
Aerobic exercise initially lasted 15 min. Time spent in target heart rate gradually 
increased 5 min/d for the first week and 3 min/d thereafter until aerobic exercise reached 
45 min. Once participants exceeded 30 min of aerobic activity, they were instructed to 
continue 3 d/wk independent of a research assistant’s supervision.  
The aerobic program in the Be Hip Mom Too! study differed in that participants 
were given pedometers (Omron Healthcare, Inc., Bannockburn, IL) to monitor steps 
taken per day. At the beginning of the intervention, participants were instructed to 
achieve a minimum of 4,000 steps/d and to increase steps by 100 to 200 per day until the 
goal of 10,000 steps were achieved. Alternatively, 3,000 aerobic steps/d were offered to 
women who had time constraints. The pedometer recorded aerobic steps as walking at 
least 100 steps/min for at least 10 min continuously. Three thousand aerobic steps have 
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been determined by previous researchers to be equivalent to walking 30 min at a brisk 
pace (11). 
 Participants in the Be Hip Mom study were instructed to not change their dietary 
intake; however, the Be Hip Mom Too! study had an additional component to the 
intervention: restricting energy intake (12). The total energy expenditure equation from 
the Dietary Reference Intakes (DRI) for overweight, non-pregnant, non-lactating women 
(13) was used to calculate energy needs. An additional 330 kcal was added for 
breastfeeding based upon the DRI recommendation, then 500 kcal was subtracted to 
promote weight loss of 1 lb/wk. No participant was prescribed an energy intake less than 
1800 kcal. Participants were asked to enter their dietary intake in MyPyramid Menu 
Planner for Moms (14) at least 3 d/wk. By doing so, dietary compliance was able to be 
measured along with individualized dietary counseling sessions.  
Control group 
The women in CG were asked not to participate in any structured exercise or 
make any changes in their diet. They were allowed to walk their infants in strollers at a 
leisurely pace (no faster than 2 mph).  
After intervention 
After the 16-wk intervention, participants in the IG were encouraged to participate 
in regular exercise. Research assistants did not monitor exercise after the intervention had 
ceased. The CG was offered the intervention program, including all exercise equipment, 
exercise protocol and instruction. Dietary counseling was also offered to the CG in the Be 
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Hip Mom Too! study. All women were contacted monthly to inquire about breastfeeding 
status and physical activity until their 1-y follow-up visit. 
Measures of Treatment 
Bone mineral density and anthropometrics 
Bone area, mineral composition and density were measured using a different dual-
energy x-ray absorptiometry machine for each study (DXA; Delphi A Version 12.3; 
Hologic, Bedford, MA for Be Hip Mom and Lunar Prodigy Adv., Lunar Radiation Corp, 
Madison, WI; QDR ENCORE software version 11.20.068 for Be Hip Mom Too!). All 3-
time points for each participant in each study were done on the same machine. The same 
trained technician scanned each participant; this ensured accuracy and precision of the 
scans. Prior to the participants being scanned, quality control was performed with a 
phantom spine. All participants lay flat in the supine position on the x-ray table while a 
total of three scans were performed: total body, lumbar spine (L1-L4) and total left hip 
(femoral neck, trochanter, and Ward’s triangle). 
Participant’s height was measured using a standardized stadiometer (235 
Heightronic Digital Stadiometer, Snoqualmie, WA) and weight was measured using a 
digital scale (Tanita BWB-800S, Arlington Heights, IL). Participants removed shoes and 
wore light clothing during measurements.  
Cardiovascular fitness and strength  
Predicted maximal oxygen consumption (VO2max) was assessed using a 
submaximal treadmill test using a modified Balke protocol in both studies. Prior to the 
treadmill test, blood pressure and resting heart rate (RHR) were measured. Predicted 
 
37 
 
maximal heart rate was calculated using the heart rate reserve formula [(220-age-RHR) x 
85% + RHR]. Participants warmed up on the treadmill for 2 to 3 min and then progressed 
to a “brisk but slightly uncomfortable” speed either by walking (< 3.7 mph) or jogging (> 
3.7 mph). This speed remained constant; however, treadmill grade increased by 2.5% 
every 2 (Be Hip Mom) or 3 (Be Hip Mom Too!) min and heart rate was recorded at this 
time. The participants wore heart monitors (Polar, Inc, Woodbury NY or Polar, Electro, 
Oy, Kempele, Finland) for the duration of the treadmill test and the test was terminated 
once participants achieved 85% of predicted maximal heart rate. Predicted VO2max was 
calculated using the following formulas obtained from ACSM (15): 
Walking: (3.5 mL·kg-1·min-1) + (speed in m·min-1 x 0.1 m·min-1) + (grade x m·min-1 x 
1.8) 
 
Jogging: (3.5 mL·kg-1·min-1) + (speed in m·min-1 x 0.2 m·min-1) + (grade x m·min-1 x 0.9) 
 
Predicted maximal oxygen consumption (VO2max) was determined using a linear 
regression equation; heart rate (HR) was defined as the independent variable and the 
dependent variable was the predicted VO2max. 
 1-RM tests were used by both studies to assess muscular strength (15). Both 
studies included squats, bench press, seated or standing military press, stiff-leg deadlifts, 
and bent-over dumbbell row. Handheld adjustable weights were used for the 1-RM and 
participants were instructed on proper form and technique for each exercise. Each 
exercise began at 40% to 60% (Be Hip Mom) or 50% to 70% (Be Hip Mom Too!) of 
perceived maximum weight capacity with 5 to 10 repetitions. The adjustable weights 
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increased in total increments of 5-, 10-, 20-lb weights until the participant could no 
longer complete the full repetition. The heaviest weight lifted without breaking proper 
form was recorded as the 1-RM. Endurance was measured in both studies by the number 
of push-up the participants could complete.  
Dietary Intake 
 Dietary intake was assessed by 24-hour dietary recalls at baseline, endpoint, and 
1-y postpartum. Recalls were collected in person or by telephone using Nutrition Data 
System for Research (NDSR, University of Minnesota) software, using a multiple pass 
system. The Be Hip Mom study conducted recalls on two separate days within the same 
week and the Be Hip Mom Too! study conducted 3 recalls. All participants were given a 
food amounts booklet to help determine portion sizes of each food item consumed. 
Results of the analyses were then averaged for each measurement period.  
Hormones and vitamin D status 
 Serum samples were collected at baseline, endpoint, and 1-y postpartum for 
analysis of hormones. A trained phlebotomist drew blood samples at the same time each 
morning, after an overnight fast to control for diurnal variation. Serum samples were then 
frozen at -70ºC until analyzed. Serum prolactin and estradiol were quantified by enzyme-
linked immunosorbent assays (ELISA) (Alpco Diagnostics, Salem, NH). All samples 
used were thawed once and analyzed in triplicate. Samples for baseline and endpoint for 
each participant were analyzed in the same assay to eliminate inter-assay variability; 
however, 1-y samples were analyzed separately. Serum samples were also analyzed, in 
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duplicate, to determine total 25-OH Vitamin D status using ELISA (DRG International, 
USA, 450 nm absorbency).  
Statistical Analysis 
 Data were analyzed with JMP software (Version 9.0.0; SAS, Cary, NC). Results 
are reported as means (SD). Characteristics of each group were compared using ANOVA 
and Pearson’s chi-squared test. Repeated-measures ANOVA was used to test for time and 
time by group differences in body weight, BMI, strength (1-RM), cardiovascular fitness 
(VO2max), dietary intake (energy, protein, calcium, vitamin D), serum vitamin D 
concentration, and hormone concentrations (prolactin and estradiol).  
The main outcome of interest in this study was the effect of exercise on BMD at 
1-y postpartum. Figure 2 is our conceptual model showing what other factors may 
influence BMD at 1-y postpartum. Those covariates identified were: serum 
concentrations of vitamin D, prolactin, and estradiol; calcium intake; and weight change 
from baseline to 1-y postpartum. Although estradiol was included in our model, it is not 
included in our data analysis because we did not record the phase of the participant’s 
menstrual cycle when serum samples were collected. Repeated-measures ANCOVA was 
used to test for time and time by group differences for bone (density, mineral content, and 
area) controlling for these covariates: percent weight change from baseline to 1-y 
postpartum; and prolactin concentration, calcium intake and vitamin D concentration at 
1-y postpartum. Statistical significance was set at p ≤ 0.05.  
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Results 
Baseline characteristics of participants who completed measurements at all 3 time 
points in each study are shown in Table 1. Prepregnant weight (p = 0.01), baseline 
weight (p = 0.01), and baseline BMI (p = 0.001) were significantly different between 
studies, because of the difference in eligibility criteria. However, there were no 
significant differences in baseline characteristics of the IG and CG of combined data 
from the 2 studies, used in this analysis (Table 2). At 1-y postpartum, the percent of 
participants still breastfeeding was higher in CG compared to IG; however, this 
difference was not significant (p = 0.14).  
Forty one percent of women in CG and 44% in IG resumed their menses at 1-y 
postpartum with the mean return of menses at 28 ± 14 in CG and 34 ± 13 wk postpartum 
in IG. Forty four percent of the women in IG and 67% of the women in CG were still 
breastfeeding at 1-y postpartum; frequency was no recorded. The average weeks 
postpartum women terminated breastfeeding was 46 ± 11 wk and 42 ± 11 wk postpartum 
in CG and IG, respectively. Ten women in CG and 9 women in IG began hormonal birth 
control during the 1-y study period. In both groups, women reported beginning hormonal 
birth control around 14 wk postpartum. Types of birth control included intrauterine 
devices, progesterone only pill, and a combination of progesterone and estrogen pill. Of 
the 19 women on birth control, 3 terminated birth control usage by 1-y postpartum (CG, n 
= 1; IG, n = 2). 
Compliance for aerobic activity was assessed for the Be Hip Mom study (n = 6) 
by how many aerobic training days were completed (total of 48 d). Women were able to 
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complete an average 41 aerobic training days (86%). In the Be Hip Mom Too! study (n = 
11), average daily steps were recorded to monitor compliance. The average daily steps 
were 5,385, only meeting 54% of our goal of 10,000 steps. Both groups experienced 
significant increases in predicted VO2max over time (Table 3). CG had higher 
measurements of predicted relative VO2max (ml/kg/min) compared to IG; however, 
absolute VO2 (L/min) did not differ between groups or by time.  
Women in IG significantly increased muscular strength in all exercises compared 
to CG. Compliance for resistance exercises was assessed by how many resistance-
training sessions were completed (total of 48 d). Women (n = 17) were able to complete 
an average of 44 resistance-training sessions (92%). Research assistants also did not 
monitor exercise after the intervention had ceased. In IG, 10 women reported 
participating in structured exercises after the 16-wk study period. Five women in CG 
reported beginning an exercise regime after the 16 wk. The average estimated duration of 
exercise after intervention to 1-y postpartum was 28 weeks. Types of exercises performed 
by both groups included running, biking, and resistance exercises. All exercises were at a 
lower intensity and frequency as the 16-wk exercises. Research assistants also did not 
monitor exercise after the intervention had ceased.  
Energy (kcal) intake in both groups significantly decreased from baseline to 1-y 
postpartum but was not significantly different between groups  (p = 0.005) (Table 4). 
Protein, calcium, and vitamin D intakes did not change from baseline to 1-y postpartum 
or between groups. The percent of energy from carbohydrates significantly decreased 
from baseline to 1-y postpartum and between groups; both protein and fat did not differ. 
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The percent of participants who met the Estimated Average Requirement for 
vitamin D (10 ug) and calcium (800 mg) is shown in Table 5; the ranges of intake are 
shown (16). Additionally, 3 women (8%, CG, n = 2; IG, n = 1) reported taking calcium 
supplements (amount unknown) at 20 weeks postpartum. At 1-y postpartum, 6 women 
(17%), 3 in each group, reported supplementing their diets with calcium. 
At baseline, 28% of the participants were categorized as having a normal BMI; 
47% and 25% were classified as overweight and obese, respectively. At 1-y postpartum, 
67% of the participants were classified as having a normal BMI, 14% were overweight, 
and 19% were obese. Weights from baseline to endpoint were significantly greater in IG 
compared to CG (p = 0.026) (Table 6). Weight change was not different between groups 
or over time. BMI significantly decreased (p = 0.001), with the change from baseline to 
endpoint significantly greater in the IG (p = 0.038). At endpoint, more participants in IG 
returned to prepregnant weight status compared to the participants in CG. At 1-y 
postpartum, approximately 30% of women returned to prepregnant weight.  
From baseline to 1-y postpartum, prolactin and estradiol concentrations in both 
groups changed significantly, p < 0.05 (Table 7). Serum vitamin D concentration did not 
differ by group or at baseline and 1-y postpartum. No correlations were observed between 
serum and dietary vitamin D; however, serum vitamin D concentrations at baseline 
correlated with serum vitamin D concentrations at 1-y postpartum (r = 0.53). Serum 
vitamin D concentration at baseline or 1-y did not correlate with BMD (lumbar spine, 
total hip, or body) or changes in BMD at any time point.  
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The mean concentrations of serum vitamin D at baseline (n = 34) and 1-y 
postpartum (n = 35) by group is shown in Table 7. The mean concentration of vitamin D 
of all study participants at baseline was 26.4 ng/mL and 25.7 ng/mL at 1-y postpartum, 
with no differences between groups. The ranges of serum vitamin D at baseline was 22.6 
– 32.5 ng/mL and 20.9 – 28.7 ng/mL at 1-y postpartum. No correlations were observed 
between serum and dietary vitamin D; however, serum vitamin D concentrations at 
baseline correlated with serum vitamin D concentrations at 1-y postpartum (r = 0.53). 
Both groups lost lumbar spine, total body, and hip BMD from baseline to 
endpoint (Table 8). At 1-y postpartum, lumbar spine and hip BMD changed over time (p 
< 0.001) but not by group. All participants were within the normal ranges of BMD levels. 
Percent changes in total body, hip, and lumbar spine BMD are shown in Table 9. Percent 
weight change from baseline to 1-y postpartum was not significantly correlated to lumbar 
spine BMD. Therefore it was not included as a covariate in our data analysis. 
Additionally, BMI was not significantly correlated with BMD. When controlling for 
dietary calcium intake and prolactin concentration at 1-y postpartum, time by group 
changes were observed. IG lost significantly less lumbar spine BMD from baseline to 1-y 
postpartum compared to CG. Additionally, no significant time or group differences were 
observed in total body or hip BMD.  
At 1-y postpartum, 7 (39%) of the 18 participants in IG had returned to their 
baseline lumbar spine BMD values (Table 10). Only 2 (11%) of the 18 participants in 
CG returned to their baseline lumbar spine BMD values. Of the 7 women in IG, 5 had 
continued exercising after intervention; 1 participant in CG who returned to baseline 
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lumbar spine values began exercising. The participants who returned lost significantly 
less lumbar spine BMD from baseline to endpoint and gained significantly more lumbar 
spine BMD from endpoint to 1-y postpartum (p < 0.05). Five participants (14%; IG = 2, 
CG = 3) returned to their baseline hip BMD values at 1-y postpartum (Table 11). Only 2 
participants (IG = 1, CG = 1) returned to both their baseline lumbar spine and hip BMD 
at 1-y postpartum.  
Discussion 
The results of this study suggest that resistance exercise during the first year 
postpartum slows BMD losses in lactating women. Few studies have examined the 
effects of exercise on BMD in breastfeeding women. In the Be Hip Mom study, the 
exercise group lost significantly less lumbar spine BMD compared to those leading 
sedentary lifestyles (-4.8 ± 0.6% vs. -7.0 ± 0.3%) (8). However, in the Be Hip Mom Too! 
study, exercise did not have a significant effect on lumbar spine BMD (IG: -3.4 ± 2.5% 
vs. -3.7 ± 3.3%). One possible explanation as to why the results were different between 
studies may be due to control participants having a higher average BMI in the Be Hip 
Mom Too! study compared to the latter (27.9 vs. 24.7 kg/m2). In our study, mean baseline 
BMI for total participants was 27.5 kg/m2; however, we did not have enough power to 
see a correlation between BMI and changes in BMD. This heavier weight may be a 
contributing factor preventing bone loss during lactation. Previous studies have shown 
that BMI is positively correlated with BMD (18); however, more recent animal research 
suggests that a high BMI is related to inflammatory makers which may negatively affect 
bone mass (19, 20). Additionally, Tanaka et al. (21) found that overweight/obese 
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postmenopausal Japanese women were at an equal risk of fractures compared to women 
who are underweight. Therefore, it is unclear whether a greater BMI provides protection 
against bone loss. 
Little and Clapp (22) compared changes in BMD of breastfeeding women 
engaging in self-selected exercise (3 d/wk, at least 20 min/d) to non-exercising 
breastfeeding women. Over the 3-mo study period, both groups lost similar amounts of 
BMD at the femoral neck (IG: -2.8 vs. CG: -2.9) and lumbar spine (IG: -4.1 vs. CG: -
5.4). The authors theorized that the variability in exercises (mode, intensity, frequency, 
and duration) was not as effective as a standardized, structured exercise program. 
Additionally, the majority of the women performed aerobic activity; resistance exercises 
may be more effective at stimulating bone growth.  
Drinkwater and Chestnut (23) followed 6 female athletes during lactation and 
compared their BMD changes to exercising, non-pregnant, non-lactating women. 
Femoral neck BMD decreased in the breastfeeding athletes; however, decreases in 
lumbar spine BMD were not observed. Although the study had the limitations of a lack of 
structured exercise and non-exercise lactating control group, the authors hypothesized 
that the exercise done by the lactating mothers may have been protective against lumbar 
spine bone loss.  
The usual bone turnover cycle occurs over 4 to 8 mo; however, during lactation, 
this cycle is shortened to 3 to 4 mo (24). It is possible that the study duration by Little and 
Clapp and Drinkwater and Chestnut may not have been long enough to see significant 
changes in BMD. The 16-wk intervention completed in both our studies was appropriate 
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to allow for multiple cycles of bone turnover. Additionally, the resistance exercise in both 
our studies targeted the core body and was successful at stimulating bone growth in the 
lumbar spine during the bone turnover cycle.  
At 1-y postpartum, only 9 participants returned to their baseline lumbar spine 
BMD and only 5 returned to baseline hip BMD. These results are different than previous 
studies that reported the majority of participants returning to baseline BMD (25, 26). The 
small number of women returning to baseline BMD may be due to a large percentage of 
women still breastfeeding in both groups (IG: 44%, CG: 67%, p = 0.18). However, mean 
prolactin and estradiol concentrations were not different between those returning to 
baseline BMD versus those still lower than baseline levels. The 9 women who returned to 
baseline BMD values lost significantly less lumbar spine BMD from baseline to endpoint 
(-2.2% vs. -5.1%) and gained significantly more from endpoint to 1-y (5.2% vs. 1.8%) 
than those who did not return to baseline lumbar spine BMD values. In addition, there 
were significantly more women in the IG versus the CG, suggesting that resistance 
exercise had a significant effect in returning to baseline BMD.  
Prolactin and estradiol concentrations were similar to those reported by Krebs et 
al. (2). From 2 to 20 wk postpartum, their study reported a decrease in prolactin from 
approximately 140 ug/L to 50 ug/L. Our prolactin concentrations were also elevated at 
baseline and declined during the 16-wk intervention, continuing to decline until 1-y 
postpartum. In their study, estradiol concentrations were elevated at 2 wk (300 pmol/L) 
and at 20 wk postpartum, estradiol concentrations decreased to 100 pmol/L. The estradiol 
concentrations in our study were also elevated at baseline and declined during the 16-wk 
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intervention; at 1-y postpartum, estradiol began to rise. Both our study and that of Krebs 
et al. (2) reported the average lumbar spine BMD loss of all participants at 20 wk 
postpartum to be approximately 4%. In their study, estradiol was positively associated 
with change in lumbar spine BMD (p < 0.001); we did not see this in our study. 
However, we did not record the phase of the participant’s menstrual cycle when serum 
samples were collected and this may be a reason why we did not see a relationship.  
Calcium and vitamin D play a major role in bone mineral density. However, their 
effects on BMD during lactation are inconclusive. Additionally, supplementation with 
calcium may not prevent bone loss during lactation, but may enhance bone formation 
after weaning (27). The Recommended Dietary Allowances of calcium for lactating and 
non-lactating women is 1,000 mg (28). Although mean dietary calcium was adequate at 
all three time points, the range of dietary calcium revealed that not all participants were 
consuming the recommendation. Calcium was included in our analysis because of the 
correlation between intake and BMD seen in previous studies. Krebs et al. (2) reported 
that adequate dietary calcium was positively associated with lumbar spine BMD at 6 mo 
after the return of menses. The average weeks postpartum that women resumed their 
menses in our study was 28 ± 14 wk for the control group and 34 ± 13 wk for the exercise 
group. Our 1-y measurements of calcium intake and BMD are approximately 6 mo after 
the return of menses for most women, similar to that observed by Krebs et al. (2). It is 
possible that adequate calcium intake is necessary for bone formation after weaning. 
However, dietary calcium intake at any time point did not correlate with BMD at any 
time point, but was a significant covariate. 
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The Recommended Dietary Allowances for vitamin D during lactation is 
currently 15 ug/d (28). All participants were given a year supply of a multivitamin 
containing 10 ug of vitamin D. Based on our results; the mean dietary vitamin D of all 
study participants was 5.2 ug, significantly lower than the RDA. It is also important to 
note that there were no significant differences between IG or CG. Dietary vitamin D was 
not correlated with lumbar spine BMD at any time point. However, vitamin D intake at 1-
y postpartum positively correlated with calcium intake at 1-y (r = 0.54). This is similar to 
the correlations found by Ghannam et al. (29).  
The serum vitamin D guidelines are controversial. Historically, vitamin D 
deficiency has been defined as < 20 ng/mL, insufficiency as 20 to 30 ng/mL, and 
sufficiency ≥ 30 ng/mL (30). Guidelines from the Institute of Medicine advise that more 
≥ 20 ng/mL is considered sufficient; a recommendation that had been under scrutiny 
since its suggestion in 2010 (31). However, a recent study conducted by Kramer et al. 
(32) exploring serum vitamin D levels in 15,099 adults who participated in the Third 
National Health and Nutrition Examination Survey, found that mortality was similar 
across the serum vitamin D range of 20 to 40 ng/mL. Using the newer guidelines from 
the Institute of Medicine, in our study, 100% of our participants at baseline and 1-yr 
postpartum were ≥ 20 ng/mL. Vitamin D concentration of lactating women has been 
previously evaluated, and our mean serum vitamin D is similar to previous studies (33, 
34). Basile et al. (33) found serum vitamin D status in lactating women from South 
Carolina to be approximately 22.4 ± 8.8 mg/dL and 28.5 ± 8.6 mg/dL, depending on the  
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study group. Additionally, Hollis et al. (34) reported a serum vitamin D of 32.9 ng/mL 
and 27.6 ng/mL in lactating participants.  
Women in IG significantly improved muscular strength over time compared to 
CG. Unfortunately, neither group saw improvements in cardiorespiratory fitness. This 
may have been due to many participants not meeting the 10,000-step/d recommendations. 
Contrary to the resistance exercises, research assistants were not present during the 
aerobic activities in the Be Hip Mom Too! study. Additionally, women in CG improved 
their cardiorespiratory fitness during the 1-y period. The CG was instructed not to 
participate in any structured exercise during the 16-wk intervention, but was allowed to 
walk their babies not faster than 2 mph. Although women in IG lost significantly more 
weight from 4 to 20 wk postpartum compared to CG, the latter had lower weight at 
baseline and lost more weight from 20 wk to 1-y postpartum. This weight loss, in both 
groups, may have contributed to the improvements in aerobic fitness, as shown by 
predicted relative VO2max.   
Additionally, our study was the first to examine the relationship between weight 
change and BMD during lactation; previous studies have examined this in the 
postmenopausal period. Wolffe et al. (35) revealed a correlation between calorie 
restriction and higher BMD losses; however, weight change in our study did not correlate 
with BMD. 
There are a number of strengths to our study. In both studies, we tested a 
supervised, randomized exercise intervention as opposed to having participants report 
exercise completed over time. By doing so, we were able to confirm compliance. The 
 
50 
 
exercise program also targeted the core body, essential in stimulating bone growth at the 
lumbar spine. BMD was also measured longitudinally at 3 time points to better 
understand the changes in bone during lactation using state of the art methods, including 
statistical analysis by repeated measures over time. Covariates were also addressed and 
controlled for during statistical analysis. A limitation is the number of dropouts due to 
pregnancy and moving away from the area. After adjusting for those who did not have 
BMD measurements at 1-y postpartum, our sample size decreased from 47 to 36. BMD 
measurements were also conducted on two different machines; however, all 3-time points 
for each participant were done on the same machine. Although the number of participants 
who took calcium supplementation were reported, it may have been more beneficial to 
record amount of calcium consumed in the supplement by these individuals. Multivitamin 
supplements containing 10 ug of vitamin D was given to each participant; however, 
compliance was difficult to measure. Additionally, most of the women resumed their 
menses at 1-y postpartum; however, we did not record the phase of the participant’s 
menstrual cycle when serum hormone levels were collected. 
In conclusion, women who participated in a 16-wk resistance and aerobic exercise 
intervention lost significantly less lumbar spine BMD during the first 20 wk postpartum, 
resulting in higher lumbar spine BMD levels at 1-y postpartum as compared to women 
who did not exercise during the postpartum period. Additional research is needed to 
determine the effects of exercise and diet on BMD during the postpartum period, given 
the low percent of women who did return to their baseline BMD levels at 1-y postpartum. 
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CHAPTER IV 
EPILOGUE 
 
 
The two studies presented in this thesis would not have been successful without 
the help and dedication of past researchers, research assistants, research staff, and 
participants. I myself have seen the study evolve in the past three years. The study 
participants and nutrition professionals that I have met while apart of the study afforded 
me the experience and confidence to continue on to improving maternal and infant health 
through nutrition. I have enjoyed my time spent on the study, especially meeting and 
working with the study participants. I began as an undergraduate research assistant in the 
Be Hip Mom Too! study. As a research assistant, I had the opportunity to interact with 
the study participants by facilitating exercise protocols, conducting laboratory 
assessments, scheduling laboratory meetings, and managing monthly follow-up call logs. 
My commitment to the study continued as I began the master’s program where I 
evaluated the two studies at one year postpartum.  
The presented research was the first to describe and compare changes in bone 
mineral density, diet, and hormone concentrations in exercising and sedentary women 
during lactation through one-year postpartum. It also examined the effects of an exercise 
intervention on the lessening of lactation-induced bone loss in mothers at one-year 
postpartum.
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Our original sample size of the combined two studies was 47; however, we lost 
many of these women at one-year follow-up due to pregnancy and the lack of availability 
by the participants. Because of this, our sample size dropped to 36 at one-year 
postpartum. A larger sample of postpartum lactating women in future studies may be 
necessary to ensure adequate power at one year.  
 Another problem that we encountered was that we measured breastfeeding status 
by call logs. Every month, we asked mothers if they were still breastfeeding; however, 
knowledge of how many times per day the women were breastfeeding was unknown. 
Calcium supplementation was also asked during these call logs, but amounts of the 
supplements were not recorded. Phase of menstrual cycle was not accounted for when the 
mother’s came into the lab for serum hormone concentration collection; therefore, our 
estradiol concentration was not a strong predictor of bone health. Another possibility for 
future research would be to account for phases in the menstrual cycles when women 
come in for their laboratory measurements to ensure accuracy of our findings.  
 After the 16-week intervention, all participants were recommended to continue 
exercising. The participants in the control group also had the opportunity to receive the 
same equipment and exercise protocol, if desired. The monthly call logs included a 
question about exercise; however, duration, type, and frequency of the exercise were not 
recorded. In a future study, the development and implementation of a different call log to 
include the items left out from the previous one would be beneficial.  
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During the study period, most participants were unable to achieve the aerobic 
activity recommendations. Many participants from the Be Hip Mom Too! study stated 
that lack of time, bad weather, illness, and lack of childcare or spousal support were the 
main barriers affecting meeting their goal. For future studies, the incorporation of 
walking groups, encouraging family walking programs, providing walking goal 
incentives, and incorporating indoor aerobic activities may help participants meet their 
aerobic goals.  
 There are a few areas for future research that I would like to see explored. The 
first would be to understand the effects of calcium and vitamin D on bone during 
lactation. Both adequate calcium and vitamin D status are essential for bone health. 
Although the majority of women met the Estimated Average Requirement for calcium, 
some participants’ intakes were far below this. Additionally, many women did not meet 
the Estimated Average Requirement for vitamin D intake. I would recruit postpartum 
lactating women, and first determine their VDR-genotype. From there, I would then 
randomize the women in each genotype into four study subgroups (subgroup 1: control, 
subgroup 2: calcium and vitamin D supplementation, subgroup 3: resistance exercise, and 
subgroup 4: resistance exercise combined with calcium and vitamin D supplementation). 
By doing this, the role of VDR-genotype will be further explored along with its role 
during exercise on BMD. It would also be important to study the concentration of serum 
vitamin D in breast milk to determine if maternal status correlates with infant vitamin D 
status. 
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 Another area of research would be to understand why so few women did not 
return to baseline BMD levels. As mentioned earlier, only 7 women returned to their 
baseline lumbar spine BMD at 1-y postpartum. Developing a longitudinal study 
examining women prior to pregnancy and following them to 2-y postpartum would be 
beneficial to understand changes in BMD.
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APPENDIX A 
 
TABLES 
 
 
 Values are means (SD) 
 1 Significantly different between studies, ANOVA, p ≤ 0.01. 
Table 1 
 
Baseline characteristics of participants who completed the 1 y measurements in the 
intervention group and control group of each study  
 
 Be Hip Mom Be Hip Mom Too! 
 Total 
Sample 
 
n = 15 
Intervention 
Group 
 
n =  7 
Control 
Group 
 
n = 8 
Total 
Sample 
 
n = 21 
Intervention 
Group 
 
n = 11 
Control 
Group 
 
n = 10 
 
Characteristic       
Age (y) 31.5 
(2.6) 
31.4 (2.2) 31.5 
(3.0) 
31.3 
(3.7) 
32.4 (3.2) 30.2 
(3.9) 
Parity (n)       
Primiparous 6 2 4 7 3 4 
Multiparous 9 5 4 14 8 6 
Prepregnancy 
weight (kg)1 
61.5 
(11.9) 
62.4 (14.2) 60.7 
(10.3) 
72.6 
(13.1) 
76.0 (8.8) 68.9 
(16.3) 
Weight (kg)1 67.9 
(12.2) 
67.0 (11.6) 68.7 
(13.4) 
78.9 
(11.6) 
83.4 (8.6) 73.9 
(12.8) 
Height (cm) 164.1 
(7.8) 
161.9 (6.5) 166.0 
(8.8) 
164.3 
(6.2) 
165.9 (5.3) 162.6 
(7.0) 
BMI (kg·m-2)1 25.1 
(3.3) 
25.5 (3.7) 24.7 
(3.1) 
29.1 
(3.4) 
30.4 (3.5) 27.8 
(2.8) 
Weeks 
postpartum at 1 y 
measurement 
52.5 
(7.5) 
53.0 (7.7) 52.1 
(7.9) 
53.5 
(2.5) 
54.1 (3.0) 52.9 
(1.9) 
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 Values are means (SD) 
 No significant differences between groups.
Table 2 
 
Baseline characteristics of participants who completed 1 y measurements in the 
intervention group and control group with data combined from two studies  
 
 Intervention Group 
n = 18 
Control Group 
n = 18 
Characteristic   
Age (y) 32.0 (2.8) 30.8 (3.5) 
Parity (n)   
Primiparous 5 8 
Multiparous 13 10 
Prepregnancy weight (kg) 70.7 (12.8) 65.2 (14.2) 
Weight (kg) 77.0 (12.6) 71.6 (13.0) 
Height (cm) 164.3 (5.9) 164.1 (7.8) 
BMI (kg·m-2) 28.5 (4.3) 26.4 (3.3) 
Weeks postpartum at 1 y 
measurement 
53.6 (5.1) 52.6 (5.3) 
% Still breastfeeding at 1 y 
measurement 
44.4% 66.7% 
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Table 3 
 
Cardiovascular fitness and muscular strength of the participants in the intervention 
and control groups 
 
 Intervention Group  Control Group  
 Baseline Endpoint 1 y Baseline Endpoint 1 y 
VO2 
(mL/kg·min) 1,2 
(CG; n = 14)  
(EG; n = 14) 
32.5 (4.5) 36.0 (5.5) 35.7 
(6.4) 
32.3 (4.6) 34.6 (6.0) 37.1 
(6.1) 
VO2 (L/min) 
(CG; n = 14)  
(EG; n = 14) 
2.5 (0.5) 2.6 (0.6) 2.5 
(0.7) 
2.3 (0.5) 2.3 (0.5) 2.4 (0.5)
Squats (lbs) 1,2 
(CG; n = 15)  
(EG; n = 13) 
78 (21) 108 (24) 98 (24) 75 (19) 86 (23) 94 (24) 
Bench press 
(lbs) 1,2 
(CG; n = 15)  
(EG; n = 13) 
47 (12) 63 (13) 60 (13) 50 (16) 52 (17) 58 (17) 
Bent-over row 
(lbs) 1,2 
(CG; n = 15)  
(EG; n = 13) 
48 (18) 70 (14) 62 (17) 46 (13) 50 (13) 57 (15) 
Deadlift (lbs) 
1,2 
(CG; n = 15) 
(EG; n = 13) 
77 (19) 109 (19) 100 
(26) 
73 (21) 81 (24) 89 (25) 
Military press 
(lbs) 1,2 
(CG; n = 15)  
(EG; n = 13) 
39 (10) 48 (8) 47 (10) 39 (10) 39 (10) 42 (10) 
 Values are means (SD) 
 1 Significantly different over time, RMANOVA, p < 0.05. 
 2 Significantly different over time between groups, RMANOVA p < 0.05.
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Values are means (SD) 
1 Significantly different over time, RMANOVA, p < 0.05. 
2 Significantly different over time between groups, RMANOVA, p < 0.05. 
2 CHO: Carbohydrates 
 
 
Table 4 
 
Reported dietary intake of the participants in the intervention and control groups 
 
 Intervention Group  Control Group  
 Baselin
e 
(n = 18) 
Endpoint 
(n = 18) 
1 y 
(n = 18) 
Baseline 
(n = 18) 
Endpoint 
(n = 18) 
1 y 
(n = 16) 
Energy 
  kcal1 2220 
(503) 
1842 
(399) 
1706 
(360) 
2131 
(571) 
1829 
(556) 
1750 (498) 
  kcal/kg 29.4 
(7.3) 
26.8 (8.9) 25.7 (8.3) 30.2 (8.2) 26.4 (4.5) 27.8 (10.4) 
% Energy from: 
  CHO2,3 52.3 
(4.6) 
54.7 (5.7) 53.3 (5.5) 51.8 (6.2) 48.7 (6.7) 49.5 (9.1) 
  Protein 16.2 
(2.6) 
16.7 (3.7) 18.1 (4.1) 15.0 (3.1) 17.7 (3.7) 19.2 (5.5) 
  Fat 33.0 
(4.3) 
30.2 (5.4) 30.1 (6.5) 34.9 (5.4) 35.3 (4.8) 33.0 (7.5) 
Protein 
  g 88.7 
(19.0) 
76.0 
(21.3) 
76.0 
(18.1) 
78.9 
(22.7) 
79.4 
(21.7) 
80.2 (22.4) 
  g/kg 1.2 
(0.3) 
1.1 (0.4) 1.1 (0.4) 1.1 (0.3) 1.2 (0.3) 1.3 (0.4) 
Calcium 
(mg) 
1366 
(477) 
1124 
(423) 
1031 
(500) 
1091 
(374) 
990 (292) 1111 (526) 
Vitamin 
D (mcg) 
5.3 
(2.6) 
4.9 (3.1) 4.8 (3.5) 4.4 (2.5) 4.5 (2.2) 5.6 (3.7) 
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EAR Estimated Average Requirement 
Table 5 
 
Dietary calcium and vitamin D intake of all participants 
 
 Baseline Endpoint 1 y 
Calcium    
% of participants that 
met the EAR of 
calcium  
(800 mg) 
81% 75% 71% 
Range (mg) 483-2068 209-1834 224-2343 
% of participants that 
met the EAR by group 
   
Intervention 89% (16/18) 83% (15/18) 67% (12/16) 
Control 72% (13/18) 67% (12/18) 75% (12/18) 
Vitamin D    
% of participants met 
the EAR of vitamin D  
(400 IU or 10 mcg) 
8% 5.5% 8.8% 
Range (mcg) 
Range (IU) 
0.995-10.6 
40-424 
0.44-11.1 
18-444 
0.617-15.78 
25-631 
% of participants met 
the EAR by group 
   
Intervention 11% (2/18) 11% (2/18) 11% (2/18) 
Control 5% (1/18) 0% (0/18) 6% (1/16) 
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Table 6 
  
Weight and weight changes of participants in the intervention and control groups 
 
 Intervention Group (n = 18) Control Group (n = 18) 
 Baseline Endpoint 1 y Baseline Endpoint 1 y 
Weight (kg)1 77.0 
(12.6) 
71.6 
(12.6) 
69.8 
(14.6) 
71.6 
(13.0) 
69.1 
(15.5) 
65.8 
(16.2)
Weight change 
Base to end2  -5.5 (3.3)   -2.5 (4.2)  
End to 1 y   -1.8 
(5.6) 
  -3.3 
(3.1) 
Base to 1 y   -7.3 
(7.8) 
  -5.8 
(4.5) 
% Weight change 
Base to end  -7.2 (4.2)   -4.0 (6.0)  
End to 1 y   -2.7 
(7.1) 
  -5.0 
(4.3) 
Base to 1 y   -9.6 
(9.4) 
  -8.9 
(6.4) 
BMI (kg·m-2)3 28.5 (4.3) 26.5 (4.4) 25.9 
(5.5) 
26.4 
(3.3) 
25.5 (4.1) 24.2 
(4.3) 
BMI change 
Base to end3  -2.0 (1.2)   -1.0 (1.6)  
End to 1 y   -0.6 
(2.0) 
  -1.2 
(1.2) 
Base to 1 y   -2.6 
(2.8) 
  -2.2 
(1.7) 
% BMI change 
Base to end  -7.2 (4.2)   -4.0 (6.0)  
End to 1 y   -2.7 
(7.1) 
  -5.0 
(4.3) 
Base to 1 y   -9.6 
(9.4) 
  -8.9 
(6.4) 
% Returning to  
prepregnant weight 
 25.0% 30.6%  16.7% 33.3
% 
 Values are means (SD) 
 1 Significantly different between groups, RMANOVA, p < 0.05. 
 2 Significantly different between groups, ANOVA, p < 0.05. 
 3 Significantly different over time, RMANOVA, p < 0.05.
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Values are means (SD) 
1 Significantly different over time, RMANOVA, p < 0.05.
Table 7 
 
Hormone concentrations of participants in the intervention and control groups 
 
 Intervention Group (n = 18) Control Group (n = 17) 
 Baseline Endpoint 1 y Baseline Endpoint 1 y 
Prolactin 
(ug/L)1 
142 (72) 61 (24) 17 (15) 156 (99) 75 (44) 23 (17) 
Estradiol 
(pmol/L)1 
139 (89) 108 (63) 176 (156) 195 (105) 125 (82) 161 
(122) 
Serum 
vitamin D 
(ng/mL) 
26.6 
(1.97) 
 26.1 
(1.51) 
26.1 
(2.26) 
 25.3 
(1.94) 
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Table 8 
 
Bone mineral density of participants in the intervention and control groups 
 
 Intervention Group (n = 18) Control Group (n = 18) 
 Baseline Endpoint 1 y Baseline Endpoint 1 y 
Total body       
BMD 
(g·cm-2) 
1.179 
(0.093) 
1.164 
(0.094) 
1.168 
(0.088) 
1.129 
(0.109) 
1.122 
(0.118) 
1.127 
(0.119) 
BMC (g) 2554 
(483) 
2494 
(455) 
2529 
(459) 
2402 
(574) 
2274 
(393) 
2289 
(494) 
Area (cm-2) 2154 
(294) 
2123 
(268) 
2160 
(278) 
2106 
(317) 
2007 
(167) 
2025 
(283) 
Lumbar 
spine 
      
BMD 
(g·cm-2) 1, 2 
1.172 
(0.126) 
1.130 
(0.128) 
1.159 
(0.128) 
1.134 
(0.156) 
1.075 
(0.149) 
1.102 
(0.149) 
BMC (g) 64 (9) 61 (9) 64 (9) 60 (10) 56 (9) 59 (9) 
Area (cm-2) 55 (5) 54 (6) 55 (5) 53 (7) 52 (7) 53 (7) 
Total hip       
BMD 
(g·cm-2) 1 
1.022 
(0.133) 
0.995 
(0.131) 
1.007 
(0.131) 
1.019 
(0.146) 
0.992 
(0.137) 
0.988 
(0.143) 
BMC (g) 32 (5) 31 (4) 32 (4) 31 (5) 30 (5) 30 (5) 
Area (cm-2) 31 (2) 31 (2) 32 (3) 30 (3) 31 (3) 31 (2) 
 Values are means (SD) 
 1 Significantly different over time, p < 0.05, RMANOVA. 
 2 Significantly different between groups, when controlling for covariates, p < 0.05,   
RMANCOVA.  
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   Values are means (SD) 
Table 9 
 
Percent changes in total body, hip, and lumbar spine BMD of participants in the 
intervention and control groups 
 
 Intervention Group Control Group 
% change from Baseline to Endpoint   
Total body -0.93 (1.04) -0.29 (1.95) 
Hip -2.58 (1.96) -2.57 (2.22) 
Lumbar spine -3.59 (2.11) -5.17 (3.28) 
% change from Endpoint to 1-y 
Postpartum 
  
Total body -0.30 (2.12) -0.39 (1.91) 
Hip 1.22 (2.99) -0.43 (2.72) 
Lumbar spine 2.66 (3.58) 2.67 (3.05) 
% change from baseline to 1-y 
postpartum 
  
Total body -1.22 (2.53) -0.70 (1.95) 
Hip -1.40 (3.14) -3.00 (3.11) 
Lumbar spine -1.05 (3.15) -2.64 (4.41) 
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Values are means (SD), unless otherwise specified 
1Significantly different between groups, ANOVA, p < 0.05. 
Table 10 
 
Characteristics of participants who returned to baseline lumbar spine BMD at 1 y  
 
 Lumbar Spine BMD 
Returned to  
Baseline 
(n = 9) 
Lumbar Spine BMD 
Did Not Return to 
Baseline 
(n = 27) 
Group, n (%)   
Exercise1 7 (78%) 11 (41%) 
Control 2 (22%) 15 (59%) 
Age (y) 30 (3.7) 32 (3.0) 
Weight (kg)   
BMI at baseline (kg/m2) 29.2 (4.5) 26.9 (3.6) 
% change in weight from 
baseline to 1 y 
-10.4 (7.2) -8.8 (8.3) 
Calcium intake at 1 y (mg/d) 914 (450) 1116 (521) 
Hormone concentration at 1 y   
Prolactin (ug/L) 23.7 (21.2) 18.8 (14.4) 
Estradiol (pmol/L) 148.8 (125.2) 175.1 (144.7) 
Menses returned (Wk 
postpartum) 
27.7 (12.4) 32.8 (14.1) 
% change in lumbar spine BMD  
baseline to endpoint1 
-2.2 (2.2) -5.1 (2.6) 
% change in lumbar spine BMD 
endpoint to 1-y1 
5.2 (2.4) 1.8 (3.1) 
Breastfeeding status at 1 y, n (%)   
Yes 3 (33%) 17 (63%) 
No 6 (67%) 10 (37%) 
Parity, n (%)   
Primiparous 5 (56%) 8 (30%) 
Multiparous 4 (44%) 19 (70%) 
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   Values are means (SD), unless otherwise specified 
   1Significantly different between groups, ANOVA, p < 0.05.
Table 11 
 
Characteristics of participants who returned to baseline total hip BMD at 1 y  
 
 Hip BMD Returned to 
Baseline 
(n = 5) 
Hip BMD Did Not 
Return to Baseline 
(n = 31) 
Group, n (%)   
Exercise  2 (40%) 16 (52%) 
Control 3 (60%) 15 (48%) 
Age (y) 30.0 (4.5) 31.6 (3.0) 
Weight (kg)   
BMI at baseline 
(kg/m2) 
26.0 (3.7) 27.7 (3.9) 
% change in weight 
from baseline to 1 y 
-6.6 (5.3) -9.6 (8.3) 
Calcium intake at 1 y (mg/d)1 637 (392) 1143 (491) 
Hormone concentration at 1 y   
Prolactin (ug/L) 10.1 (10.0) 21.7 (16.6) 
Estradiol (pmol/L) 169.0 (129.9) 168.3 (142.1) 
Menses returned (Wk 
postpartum) 
32.6 (11.0) 31.2 (14.4) 
% change in hip BMD  
baseline to endpoint1 
-0.4 (2.1) -2.9 (1.9) 
% change in hip BMD  
endpoint to 1 y1 
3.4 (3.8) -0.1 (2.5) 
Breastfeeding status at 1 y, n 
(%) 
  
Yes 1 (20%) 19 (61%) 
No 4 (80%) 12 (39%) 
Parity, n (%)   
Primiparous 1 (20%) 12 (39%) 
Multiparous 4 (80%) 19 (61%) 
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APPENDIX B 
FIGURES 
 
 
Figure 1. Study Design of Participants 
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Figure 2. Conceptual Model 
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